EDAP TMS Sets May 7 for Q1 2026 Earnings Release
Event summary
- EDAP TMS SA will release its first-quarter 2026 financial results on May 7, 2026.
- Conference call and webcast scheduled for 8:30 a.m. EDT with CEO Ryan Rhodes, CFO Ken Mobeck, and CAO François Dietsch.
- Company is a global leader in robotic energy-based therapies, known for its Focal One® prostate focal therapy device.
The big picture
EDAP TMS's upcoming earnings release comes at a time when the demand for minimally invasive medical technologies is rising. The company's focus on robotic energy-based therapies positions it well in the growing market for precise, non-invasive treatments. Investors will be watching closely to see if EDAP TMS can maintain its leadership position and expand into new indications.
What we're watching
- Revenue Growth
- Whether EDAP TMS can sustain its growth trajectory in the robotic energy-based therapies market.
- Market Expansion
- The pace at which EDAP TMS expands the Focal One® device into indications beyond prostate cancer.
- Competitive Positioning
- How EDAP TMS differentiates itself in a competitive landscape of minimally invasive medical devices.
Related topics